Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kirkwood

Showing results (1-10 of 670) with videos related to

Pageof 67
Sort By:
Lancet (London, England)|July 8, 1998
Adjuvant IFN alpha2 therapy of melanomaJ M Kirkwood
Immunology Series|January 1, 1994
The role of interferons in the therapy of melanomaJ M Kirkwood
Lancet (London, England)|November 29, 1975
Letter: Is pre-eclampsia an immune-complex disease?E M Kirkwood
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapiesJ M Kirkwood
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Response to letter to the editor on "Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76K trial"John M Kirkwood
Pigment Cell & Melanoma Research|July 26, 2011
Melanoma response and resistance - taking it to the tumor bankJohn M Kirkwood
Seminars in Oncology|October 1, 1991
Studies of interferons in the therapy of melanomaJ M Kirkwood
British Journal of Cancer|May 19, 2000
Adjuvant interferon in the treatment of melanomaJ M Kirkwood
Current Opinion in Oncology|March 1, 1994
Systemic therapy of melanomaJ M Kirkwood
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Building upon the standard of care in adjuvant therapy of high-risk melanomaJohn M Kirkwood
Pageof 67

Showing results (1-10 of 670) with videos related to

Sort By:
Pageof 67
Lancet (London, England)|July 8, 1998
Adjuvant IFN alpha2 therapy of melanomaJ M Kirkwood
Immunology Series|January 1, 1994
The role of interferons in the therapy of melanomaJ M Kirkwood
Lancet (London, England)|November 29, 1975
Letter: Is pre-eclampsia an immune-complex disease?E M Kirkwood
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapiesJ M Kirkwood
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Response to letter to the editor on "Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76K trial"John M Kirkwood
Pigment Cell & Melanoma Research|July 26, 2011
Melanoma response and resistance - taking it to the tumor bankJohn M Kirkwood
Seminars in Oncology|October 1, 1991
Studies of interferons in the therapy of melanomaJ M Kirkwood
British Journal of Cancer|May 19, 2000
Adjuvant interferon in the treatment of melanomaJ M Kirkwood
Current Opinion in Oncology|March 1, 1994
Systemic therapy of melanomaJ M Kirkwood
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Building upon the standard of care in adjuvant therapy of high-risk melanomaJohn M Kirkwood
Pageof 67